Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.80), $0.11 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $3.5 million.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.